Price T Rowe Associates Inc Aspira Women'S Health Inc. Transaction History

Price T Rowe Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $24,530 - $66,846	-61,327 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.88 - $1.81 $2,024 - $4,163	2,300 Added 3.9%	61,327 $64,000
Q4 2021 Feb 14, 2022	SELL	$1.63 - $3.43 $1,863 - $3,920	-1,143 Reduced 1.9%	59,027 $104,000
Q3 2021 Nov 15, 2021	BUY	$3.19 - $5.48 $105,908 - $181,936	33,200 Added 123.1%	60,170 $196,000
Q2 2021 Aug 16, 2021	SELL	$4.78 - $6.84 $3,331 - $4,767	-697 Reduced 2.52%	26,970 $152,000
Q1 2021 May 17, 2021	SELL	$5.9 - $9.13 $68,611 - $106,172	-11,629 Reduced 29.59%	27,667 $187,000
Q4 2020 Feb 16, 2021	BUY	$3.0 - $6.71 $117,888 - $263,676	39,296 New	39,296 $264,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.